453 related articles for article (PubMed ID: 31267597)
1. Non-invasive visual evoked potentials to assess optic nerve involvement in the dark agouti rat model of experimental autoimmune encephalomyelitis induced by myelin oligodendrocyte glycoprotein.
Castoldi V; Marenna S; d'Isa R; Huang SC; De Battista D; Chirizzi C; Chaabane L; Kumar D; Boschert U; Comi G; Leocani L
Brain Pathol; 2020 Jan; 30(1):137-150. PubMed ID: 31267597
[TBL] [Abstract][Full Text] [Related]
2. Electrophysiological and Histological Correlations of Optic Neuritis in the Dark Agouti Rat Model of Experimental Autoimmune Encephalomyelitis.
Lotan I; Nishiyama S; Wright A; Myoung Seok J; Levy M
Neuroscience; 2023 Aug; 524():89-93. PubMed ID: 37290683
[TBL] [Abstract][Full Text] [Related]
3. Dose-dependent effect of myelin oligodendrocyte glycoprotein on visual function and optic nerve damage in experimental autoimmune encephalomyelitis.
Castoldi V; Marenna S; Huang SC; d'Isa R; Chaabane L; Comi G; Leocani L
J Neurosci Res; 2022 Mar; 100(3):855-868. PubMed ID: 35043454
[TBL] [Abstract][Full Text] [Related]
4. Loss of Nrf2 exacerbates the visual deficits and optic neuritis elicited by experimental autoimmune encephalomyelitis.
Larabee CM; Desai S; Agasing A; Georgescu C; Wren JD; Axtell RC; Plafker SM
Mol Vis; 2016; 22():1503-1513. PubMed ID: 28050123
[TBL] [Abstract][Full Text] [Related]
5. Optic nerve involvement in experimental autoimmune encephalomyelitis to homologous spinal cord homogenate immunization in the dark agouti rat.
Castoldi V; Marenna S; Santangelo R; d'Isa R; Cursi M; Chaabane L; Quattrini A; Comi G; Leocani L
J Neuroimmunol; 2018 Dec; 325():1-9. PubMed ID: 30340030
[TBL] [Abstract][Full Text] [Related]
6. Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
Prinz J; Karacivi A; Stormanns ER; Recks MS; Kuerten S
PLoS One; 2015; 10(12):e0144847. PubMed ID: 26658811
[TBL] [Abstract][Full Text] [Related]
7. Role of pathogenic T cells and autoantibodies in relapse and progression of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis in LEW.1AV1 rats.
Matsumoto Y; Park IK; Hiraki K; Ohtani S; Kohyama K
Immunology; 2009 Sep; 128(1 Suppl):e250-61. PubMed ID: 19175799
[TBL] [Abstract][Full Text] [Related]
8. Transcranial direct current stimulation as a preventive treatment in multiple sclerosis? Preclinical evidence.
Marenna S; Huang SC; Rossi E; Castoldi V; Comi G; Leocani L
Exp Neurol; 2022 Nov; 357():114201. PubMed ID: 35963325
[TBL] [Abstract][Full Text] [Related]
9. Functional evolution of visual involvement in experimental autoimmune encephalomyelitis.
Marenna S; Huang SC; Castoldi V; d'Isa R; Costa GD; Comi G; Leocani L
Mult Scler J Exp Transl Clin; 2020; 6(4):2055217320963474. PubMed ID: 35145730
[TBL] [Abstract][Full Text] [Related]
10. Alterations of peripheral nerve excitability in an experimental autoimmune encephalomyelitis mouse model for multiple sclerosis.
Teixeira NB; Picolo G; Giardini AC; Boumezbeur F; Pottier G; Kuhnast B; Servent D; Benoit E
J Neuroinflammation; 2020 Sep; 17(1):266. PubMed ID: 32894170
[TBL] [Abstract][Full Text] [Related]
11. Axon loss is responsible for chronic neurological deficit following inflammatory demyelination in the rat.
Papadopoulos D; Pham-Dinh D; Reynolds R
Exp Neurol; 2006 Feb; 197(2):373-85. PubMed ID: 16337942
[TBL] [Abstract][Full Text] [Related]
12. Cathepsin C modulates myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis.
Durose WW; Shimizu T; Li J; Abe M; Sakimura K; Chetsawang B; Tanaka KF; Suzumura A; Tohyama K; Ikenaka K
J Neurochem; 2019 Feb; 148(3):413-425. PubMed ID: 30152001
[TBL] [Abstract][Full Text] [Related]
13. Alleviation of extensive visual pathway dysfunction by a remyelinating drug in a chronic mouse model of multiple sclerosis.
Sekyi MT; Lauderdale K; Atkinson KC; Golestany B; Karim H; Feri M; Soto JS; Diaz C; Kim SH; Cilluffo M; Nusinowitz S; Katzenellenbogen JA; Tiwari-Woodruff SK
Brain Pathol; 2021 Mar; 31(2):312-332. PubMed ID: 33368801
[TBL] [Abstract][Full Text] [Related]
14. Translocator Protein Ligand PIGA1138 Reduces Disease Symptoms and Severity in Experimental Autoimmune Encephalomyelitis Model of Primary Progressive Multiple Sclerosis.
Tremolanti C; Cavallini C; Meyer L; Klein C; Da Pozzo E; Costa B; Germelli L; Taliani S; Patte-Mensah C; Mensah-Nyagan AG
Mol Neurobiol; 2022 Mar; 59(3):1744-1765. PubMed ID: 35018577
[TBL] [Abstract][Full Text] [Related]
15. The response of NG2-expressing oligodendrocyte progenitors to demyelination in MOG-EAE and MS.
Reynolds R; Dawson M; Papadopoulos D; Polito A; Di Bello IC; Pham-Dinh D; Levine J
J Neurocytol; 2002; 31(6-7):523-36. PubMed ID: 14501221
[TBL] [Abstract][Full Text] [Related]
16. Congenic mapping confirms a locus on rat chromosome 10 conferring strong protection against myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis.
Jagodic M; Kornek B; Weissert R; Lassmann H; Olsson T; Dahlman I
Immunogenetics; 2001 Jul; 53(5):410-5. PubMed ID: 11486278
[TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory cytokine gene therapy decreases sensory and motor dysfunction in experimental Multiple Sclerosis: MOG-EAE behavioral and anatomical symptom treatment with cytokine gene therapy.
Sloane E; Ledeboer A; Seibert W; Coats B; van Strien M; Maier SF; Johnson KW; Chavez R; Watkins LR; Leinwand L; Milligan ED; Van Dam AM
Brain Behav Immun; 2009 Jan; 23(1):92-100. PubMed ID: 18835435
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological study of a myelin oligodendrocyte glycoprotein-induced demyelinating disease in LEW.1AV1 rats.
Sakuma H; Kohyama K; Park IK; Miyakoshi A; Tanuma N; Matsumoto Y
Brain; 2004 Oct; 127(Pt 10):2201-13. PubMed ID: 15282218
[TBL] [Abstract][Full Text] [Related]
19. Characterization of relapsing-remitting and chronic forms of experimental autoimmune encephalomyelitis in C57BL/6 mice.
Berard JL; Wolak K; Fournier S; David S
Glia; 2010 Mar; 58(4):434-45. PubMed ID: 19780195
[TBL] [Abstract][Full Text] [Related]
20. Laquinimod protects the optic nerve and retina in an experimental autoimmune encephalomyelitis model.
Wilmes AT; Reinehr S; Kühn S; Pedreiturria X; Petrikowski L; Faissner S; Ayzenberg I; Stute G; Gold R; Dick HB; Kleiter I; Joachim SC
J Neuroinflammation; 2018 Jun; 15(1):183. PubMed ID: 29903027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
